Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Human Metabolome Technologies, Inc.
No Price
Closing Price XTKS 28.04.2026:
696,00 JPY
28.04.2026 06:30
Current Prices from Human Metabolome Technologies, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
6090.T
JPY
28.04.2026 06:30
696,00 JPY
-4,00 JPY
-0,57 %
Share Float & Liquidity
Free Float72,15 %
Shares Float4,06 M
Shares Outstanding5,63 M
Company Profile for Human Metabolome Technologies, Inc. Share
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.
